Please select the option that best describes you:
Topics:
Neurology • Neuromuscular
How do you counsel patients with genetically confirmed Fabry disease regarding switching from agalsidase beta (Fabrazyme) to Migalastat (Galafold)?
Assuming they have an amenable gene